DBRC
NVS icon

D.B. Root & Company’s Novartis NVS Stock Holding History

D.B. Root & Company’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,902
Closed -$377K – 192
2024
Q1 		$377K Sell
3,902
-153
-4% -$15.7K 0.13% 129
2023
Q4 		$409K Sell
4,055
-572
-12% -$55.2K 0.15% 123
2023
Q3 		$471K Buy
4,627
+90
+2% +$9.13K 0.18% 111
2023
Q2 		$458K Sell
4,537
-3,826
-46% -$383K 0.17% 120
2023
Q1 		$769K Buy
8,363
+192
+2% +$16.8K 0.3% 88
2022
Q4 		$741K Sell
8,171
-435
-5% -$36.6K 0.31% 85
2022
Q3 		$654K Buy
8,606
+62
+0.7% +$5.14K 0.3% 87
2022
Q2 		$722K Sell
8,544
-104
-1% -$9.12K 0.31% 83
2022
Q1 		$758K Buy
8,648
+82
+1% +$7.1K 0.28% 89
2021
Q4 		$749K Sell
8,566
-103
-1% -$8.55K 0.27% 97
2021
Q3 		$708K Sell
8,669
-1,473
-15% -$133K 0.28% 102
2021
Q2 		$925K Buy
10,142
+553
+6% +$49.2K 0.35% 79
2021
Q1 		$819K Sell
9,589
-3,638
-28% -$326K 0.32% 86
2020
Q4 		$1.25M Sell
13,227
-157
-1% -$13.7K 0.5% 43
2020
Q3 		$1.16M Buy
13,384
+65
+0.5% +$5.63K 0.47% 48
2020
Q2 		$1.16M Sell
13,319
-300
-2% -$25.9K 0.51% 44
2020
Q1 		$1.12M Sell
13,619
-50
-0.4% -$4.46K 0.57% 40
2019
Q4 		$1.29M Sell
13,669
-65
-0.5% -$5.83K 0.57% 38
2019
Q3 		$1.19M Sell
13,734
-705
-5% -$63.3K 0.56% 42
2019
Q2 		$1.32M Sell
14,439
-1,999
-12% -$169K 0.58% 39
2019
Q1 		$1.42M Sell
16,438
-247
-1% -$19.8K 0.6% 41
2018
Q4 		$1.28M Buy
16,685
+2,816
+20% +$219K 0.64% 42
2018
Q3 		$1.07M Sell
13,869
-301
-2% -$22.3K 0.47% 66
2018
Q2 		$959K Buy
14,170
+770
+6% +$53.1K 0.45% 72
2018
Q1 		$971K Buy
+13,400
New +$1.02M 0.51% 62

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCM
Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

D.B. Root & Company's NVS Position: Q2 2024 in Review

D.B. Root & Company sold out of Novartis (NVS) in Q2 2024, closing a stake of 3,902 shares — an estimated $377K sold.

D.B. Root & Company first reported a position in NVS in Q1 2018 and held it in 25 quarters. The position peaked at $1.42M in Q1 2019. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

  • D.B. Root & Company reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
  • D.B. Root & Company sold 3,902 Novartis shares in Q2 2024, an estimated $377K.
  • D.B. Root & Company first reported a position in Novartis in Q1 2018 and held it in 25 quarters.
  • D.B. Root & Company's Novartis position peaked at $1.42M in Q1 2019.
  • 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on D.B. Root & Company's 13F filing for Q2 2024, filed 15 Jul 2024.